Angiotensin-(1-7) ameliorates intestinal barrier dysfunction by activating the Keap1/Nrf2/HO-1 signaling pathway in acute pancreatitis
- PMID: 37269386
- DOI: 10.1007/s11033-023-08544-9
Angiotensin-(1-7) ameliorates intestinal barrier dysfunction by activating the Keap1/Nrf2/HO-1 signaling pathway in acute pancreatitis
Abstract
Background: Intestinal barrier dysfunction is a serious complication associated with acute pancreatitis (AP). Angiotensin (Ang)-(1-7) plays a protective role in the intestinal barrier, but the underlying mechanism remains clear. This study investigated the impact of Ang-(1-7) on AP-induced intestinal dysfunction and its involvement in the Keap1/Nrf2/HO-1 pathway.
Methods and results: We studied caerulein- and lipopolysaccharide (LPS)-induced AP in mice and an epithelial cell line (IEC-6) from the small intestinal crypt of rats. Ang-(1-7) was administered orally or via the tail vein. IEC-6 cells were divided into five groups: control; LPS; LPS + Ang-(1-7); LPS + Ang-(1-7) + ML385 (an Nrf2 inhibitor); and LPS + ML385. Pancreatic and intestinal histopathology scores were analyzed using the Schmidt and Chiu scores. The expression of intestinal barrier-associated proteins and Keap1/Nrf2/HO-1 pathway constituents was assessed by RT-PCR and western blotting. The peroxide and antioxidant activities in the IEC-6 cells were measured. Compared to those in AP mice, Ang-(1-7) diminished the intestinal levels of proinflammatory factors (interleukin-1β and tumor necrosis factor α) and serum levels of intestine permeability (D-lactate). Ang-(1-7) increased the expression of barrier-associated proteins (aquaporin-1, claudin-1, and occludin) compared to those in the AP and LPS group. Moreover, Ang-(1-7) promoted the Keap/Nrf2/HO-1 pathway, which resulted in significantly reduced malondialdehyde and increased superoxide dismutase levels.. However, ML385 abolished the effects of Ang-(1-7) on barrier-associated proteins and reversed the Keap1/Nrf2/HO-1 pathway.
Conclusions: Ang-(1-7) reduces AP-induced intestinal inflammation and oxidative injuries by activating the Keap1/Nrf2/HO-1 pathway.
Keywords: Acute pancreatitis; Ang-(1–7); Intestinal barrier; Intestinal inflammation; Oxidative stress.
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
[Paeoniflorin Improves Acute Lung Injury in Sepsis by Activating Nrf2/Keap1 Signaling Pathway].Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 Sep;51(5):664-669. doi: 10.12182/20200960201. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 32975081 Chinese.
-
Bufalin alleviates inflammatory response and oxidative stress in experimental severe acute pancreatitis through activating Keap1-Nrf2/HO-1 and inhibiting NF-κB pathways.Int Immunopharmacol. 2024 Dec 5;142(Pt A):113113. doi: 10.1016/j.intimp.2024.113113. Epub 2024 Sep 13. Int Immunopharmacol. 2024. PMID: 39276459
-
S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.Int Immunopharmacol. 2020 Apr;81:106273. doi: 10.1016/j.intimp.2020.106273. Epub 2020 Mar 5. Int Immunopharmacol. 2020. PMID: 32070920
-
Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation.Free Radic Biol Med. 2022 Sep;190:264-275. doi: 10.1016/j.freeradbiomed.2022.08.016. Epub 2022 Aug 14. Free Radic Biol Med. 2022. PMID: 35977659 Review.
-
A Protective Role of the NRF2-Keap1 Pathway in Maintaining Intestinal Barrier Function.Oxid Med Cell Longev. 2019 Jun 26;2019:1759149. doi: 10.1155/2019/1759149. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31346356 Free PMC article. Review.
Cited by
-
The Effect of Protein Nutritional Support on Inflammatory Bowel Disease and Its Potential Mechanisms.Nutrients. 2024 Jul 17;16(14):2302. doi: 10.3390/nu16142302. Nutrients. 2024. PMID: 39064745 Free PMC article. Review.
References
-
- Petrov MS, Yadav D (2019) Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 16(3):175–184. https://doi.org/10.1038/s41575-018-0087-5 - DOI - PubMed - PMC
-
- Boxhoorn L, Voermans RP, Bouwense SA et al (2020) Acute pancreatitis. Lancet 396(10252):726–734. https://doi.org/10.1016/S0140-6736(20)31310-6 - DOI - PubMed
-
- Wei B, Wu Q, Yang X, Lai C, Su Z (2022) Liang Z (2022) Effect of TRAF6 in acute pancreatitis-induced intestinal barrier injury via TLR4/NF-κB signal pathway. Tissue Cell. 76:101792. https://doi.org/10.1016/j.tice.2022.101792 - DOI - PubMed
-
- Agarwala R, Rana SS, Sharma R et al (2020) Gastrointestinal failure is a predictor of poor outcome in patients with acute pancreatitis. Dig Dis Sci 65(8):2419–2426. https://doi.org/10.1007/s10620-019-05952-5 - DOI - PubMed
-
- Scaldaferri F, Pizzoferrato M, Gerardi V et al (2012) The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol 46(Suppl):S12–S17. https://doi.org/10.1097/MCG.0b013e31826ae849 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous